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Abstract Nucleoside diphosphate kinase (NDPK) has
many roles and is present in different locations in the cell.
Membrane-bound NDPK is present in epithelial fractions
enriched for the apical membrane. Here, we show in
human, mouse and sheep airway membranes, that the
phosphorylation state of membrane-bound NDPK on his-
tidine and serine residues differs dependent on many reg-
ulatory factors. GTP (but not ATP) promotes serine
phosphorylation (pSer) of NDPK. Further we ﬁnd that
rising [AMP] promotes pSer (only with GTP) but inhibits
histidine phosphorylation (pHis) of NDPK from both
donors. We ﬁnd that NDPK co-immunoprecipitates recip-
rocally with AMP-activated kinase and that these two
proteins can co-localise in human airways. AMP concen-
trations rise rapidly when ATP is depleted or during
hypoxia. We ﬁnd that, in human airway cells exposed to
hypoxia (3% oxygen), membrane-bound NDPK is inhib-
ited. Although histidine phosphorylation should in princi-
ple be independent of the nucleotide triphosphates used, we
speculate that this membrane pool of NDPK may be able to
switch function dependent on nucleotide species.
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Introduction
A number of studies have suggested that phosphorylation
of nucleoside diphosphate kinase (NDPK or NM23) may
be important for function. For example, it was found that
the wild-type NM23-H1 isoform suppressed the motility of
cancer cells when over-expressed, but the NM23-H1
S120G or S120A mutants were unable to do so [1, 2]. It
was later reported that S120 is a target for phosphorylation
by CK2, which inhibits the auto-phosphorylation of H118
[3]. This histidine phosphorylation was also found to
be defective in the pancreatic islets of a diabetic (Goto-
Kakizaki) rat model, which exhibits defective regulation of
insulin secretion [4]. Islet cells are unusual in that insulin
secretion in response to glucose does not require a glucose
receptor at the cell membrane. Instead, the metabolism of
glucose regulates insulin secretion. Protein phosphoryla-
tion by multiple kinases regulates this process and AMP-
activated kinase (AMPK) plays a pivotal role [5]. Here we
explore the potential interaction between NDPK and
AMPK in an epithelial context.
An important difference between a non-polarised cell
such as a fat or muscle cell and an epithelial cell lies in
the separation of distinct domains of the plasma mem-
brane. This difference occurs because epithelial cells face
the external environment and have evolved apical mem-
branes with different lipid and protein compositions
compared to their inward facing basolateral membranes
that are in contact with the interior spaces of the organ-
ism. These differences reﬂect the different functions
required of the two membranes. To study epithelial
membrane function, the puriﬁed apical membrane of the
ovine tracheal epithelium has proved to be a useful
resource and this led to our discovery of membrane-bound
pools of nucleoside diphosphate kinase (NDPK, isoforms
NM23-H1 and NM23-H2). It was found [6, 7] that this
NDPK exists in at least two pools with different binding
characteristics to the membrane. We discovered these
NDPK pools whilst studying the relationship between the
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phosphorylation of annexin I in the apical membrane of
the tracheal epithelium. We found that cAMP inhibits the
histidine phosphorylation of annexin I, and AMP was as
effective an inhibitor as cAMP [8]. In that study we used
EDTA to extract divalent cation-dependent proteins from
the membrane. One NDPK pool (predominantly NDPK A,
NM32-H1) could be extracted with EDTA whereas
another remained tightly membrane-attached [6–9]. Since
NDPK is reported to interact with cAMP [10, 11], we
employed cAMP afﬁnity chromatography and found that
cAMP interacted differentially with these pools such that
the EDTA-extracted pool, but not the membrane-retained
(CHAPS-solubilised) pool of NDPK was able to bind.
That these EDTA-extractable and membrane-retained
NDPK fractions were indeed different was further
exempliﬁed when each pool was overlaid onto blots
bearing the same membranes separated by SDS-PAGE
(far-western technique). NDPK from the CHAPS-solubi-
lised tracheal membranes was found to bind a 63 kDa
protein in addition to itself, but the EDTA-extracted
fraction displayed no binding at this molecular weight.
Attempts were then made to determine the identity and
regulatory properties of this 63 kDa protein, which led to
our proposal that it was the a subunit of AMPK. How-
ever, these conclusions have recently been confounded by
retraction of two papers from 2006 and 2007 (Crawford
et al. Mol Cell Biol and FASEB J, respectively), which
proposed a mechanism of kinase–kinase interaction
between protein kinase CK2 (formerly casein kinase 2)
[12], NDPK and the 63 kDa a-subunit of AMPK [13–15].
Therefore, we have re-evaluated our previously unpub-
lished data (from 2000–2002) and present this earlier
evidence for an interaction between NDPK and AMPK
here. These data represent observations made by KJT
during her Wellcome Trust supported fellowship.
This article focusses on membrane-associated NDPK
and considers the factors controlling the histidine auto-
phosphorylation of this protein histidine kinase in the
apical membranes of epithelia. We explore the phosphor-
ylation of this membrane-bound fraction of NDPK and
discuss its potential partners, factors inﬂuencing the level
of NDPK phosphorylation and the relationship of the latter
to the labelling of other membrane proteins. The regulatory
mechanisms we have observed are conserved across three
species (mouse, sheep, human). The data point to a link to
[AMP], reinforce the likely interaction with AMPK and
show that this NDPK, when in a membrane environment,
can discriminate between ATP and GTP. Since this
mechanism cannot be explained by in vitro enzymology
(NDPK as a pure enzyme has no selectivity for the base
moiety within the nucleoside); this suggests additional
regulation of NDPK.
Methods
Brieﬂy, we studied either (a) airway biopsies fractionated
to enrich for apical membranes using discontinuous
sucrose density gradient centrifugation (Treharne et al.
1994), (b) a cytosol free pellet (P4) of *6 fold apically
enriched sheep tracheal membranes which we previously
used to purify NDPK and annexins [8], (c) plasma
membranes puriﬁed from monolayers of a cultured human
airway cell line (HBE [16, 17] or (d) various murine
preparations of gut, lung and nasal airway epithelia. For
the latter, mice were reared in ethically-approved facilities
compliant with local legislation and euthanased by
approved regulatory schedules. Bowel was ﬂushed with
saline, and the lumenal surface was scraped with a glass
slide to harvest the epithelial cells. In each case, puriﬁed
membranes were solubilised in MOPS-Triton buffers as
described in [18], proteins separated by SDS-PAGE using
lower gel buffer at either pH 8.9 or 6.5 and phospho-
proteins were visualised without acid treatment of gels by
electronic autoradiography (Perkin Elmer, Instant Imager).
For some studies on phosphohistidine (pHis) and phos-
phoserine (pSer) membranes were treated with acid
(0.1 M HCl) or alkali (0.1 M NaOH) prior to running the
gels and autoradiography.
A human bronchial epithelial cell line (16HBE14o-,
HBE) was cultured on transwell membranes at air–liquid
interface for three weeks at different pO2 levels before
ﬁxation for immunoﬂuorescent analysis. Membranes with
cells attached were stained using antibodies speciﬁc for
NDPK and AMPK a1.
NDPK classically transfers c-phosphates between
nucleoside triphosphates and diphosphates. However,
under the above phosphorylation conditions (no exogenous
Mg
2? added, but in the absence of EDTA) at low tem-
perature, the activity of membrane-bound NDPK was
below the limit of detection (data not shown). To determine
that NDPK could be active in these membranes, the rate of
transfer of
32P from c[
32P]ATP (or GTP) to a GDP (or
ADP) acceptor was measured at 37C over the linear range
(Fig. 1c). This activity is equivalent to GTP generation at
*55 pmol/lg protein/min. It must be emphasised that this
refers to total membrane protein. We conﬁrmed that human
airway cell membranes derived from nasal brushings could
also transfer phosphate in this manner and similar transfer
was observed for mouse and sheep airway epithelial
membranes (not shown). Antibodies to NDPK were
108 Mol Cell Biochem (2009) 329:107–114
123purchased from Santa Cruz. AMPK antibodies were a kind
gift of D.G. Hardie, Dundee. All reagents were of analyt-
ical grade.
Results
NDPK is an early phosphoprotein (within one minute)
labelled at 4C in airway membranes from human, mouse
and sheep airway [9, 18]. When a 6–15 fold apically
enriched epithelial membrane preparation of airway epi-
thelium was incubated with c[
32P]ATP (or GTP) at 4C for
*1–5 min, we observed only one pair of *18 kDa
phosphoproteins, which we showed to be isoforms A and B
(NM23-H1/H2) of nucleoside diphosphate kinase (NDPK).
Furthermore, the acid lability of this labelling suggested
that the c-phosphate had been transferred to phosphohisti-
dine, to H118 in the active site [9]. Figure 1a shows that
this phosphorylation is inhibited when the reaction is per-
formed in the presence of 1 mM AMP both in ovine
(Fig. 1a, left panel) and human epithelial membranes
(Fig. 1a, right panel). This inhibition was investigated
further using human primary apical membranes and a dose
response to AMP. These data show that the IC50 is around
200 lM for AMP, similar for UMP, but is about 30 lM for
GMP. However, we observe that the inhibition occurs with
a common rapid phase between 0 and 50 lM for all
nucleotides tested, followed by a much slower phase up to
1 mM. The potent effects of GMP were not explored fur-
ther. To test the function of this membrane-associated
NDPK, a human airway cell line (HBE), as well as epi-
thelial membranes from murine gut were tested for NDPK
activity. We observed that GTP was generated with similar
kinetics from each membrane preparation and the rate was
linear for 1.5 min (Fig. 1c).
In addition to the autophosphorylation of NDPK at
H118, this protein can also be phosphorylated on a serine
residue adjacent to the H118 [3], however, this study was
conducted before the advent of mass spectrometry. To date,
no absolute identiﬁcation of this serine being phosphory-
lated has been performed. These serine and histidine
phospho-amino acids may be distinguished by their distinct
pH lability (only phosphohistidine is acid-labile in SDS-
PAGE gels buffered to pH 6.5). The upper panel of Fig. 2
shows that, when ATP is the phospho-donor, NDPK has no
detectable acid-stable phosphorylation (i.e. no detected
pSer at pH 6.5, implying that only pHis must have been
present). In contrast, GTP as phosphate donor results in a
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Fig. 1 Effect of nucleotides on NDPK phosphorylation. a Phosphor-
ylation of NDPK at 4C is inhibited by 1 mM AMP in both ovine (left
panel) and human (right panel) membranes run in triplicate; NDPK
typically shows up as a phosphorylated doublet in human membranes.
b Dose response of human NDPK phosphorylation to AMP, GMP and
UMP. c Membrane activity (transfer of c-phosphate from ATP to
GDP) of NDPK from human (HBE cell line) and mouse gut epithelia
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123small amount of acid-stable labelling of NDPK. Quantiﬁ-
cation (Fig. 2, lower panel, note that the left and right y
axes are on different scales) shows that this acid-stable
labelling is a quarter of the phosphorylation observed at pH
8.9. Furthermore, with increasing AMP concentration, this
acid-stable labelling increases by ﬁfty percent, despite the
total phosphorylation (at the same time) declining to ten
and sixty percent for ATP and GTP respectively.
AMP has many cellular effects, but it is increasingly
recognised that AMP-activated protein kinase (AMPK)
mediates many of these [15, 19] and its catalytic subunit
has a molecular weight of 63 kDa. We therefore investi-
gated whether AMPK could affect the NDPK studied in
these experiments. Figure 3 shows that the addition of
immunoprecipitated AMPK increased the total (*nine-
fold), histidine (*nine-fold) and serine (six-fold) phos-
phorylation of NDPK in the absence of AMP. In the
presence of AMP, this increase was attenuated (5-fold).
Serine phosphorylation was negligible relative to pHis. We
interpret these data to suggest that AMPK, independent of
AMP, can augment NDPK (auto)phosphorylation and may
enhance its serine phosphorylation (dependent on the
nucleotide donor). In contrast, the addition of AMP makes
AMPK less able to augment the autophosphorylation of
NDPK. Although these data are apparently in conﬂict with
each other, they nevertheless imply that the two proteins
may interact in both AMP-dependent and independent
modes and this was tested in different ways. We showed
that the two protein kinases co-immunoprecipitate recip-
rocally from ovine airway membranes and HBE cell
membranes (Fig. 4, panels a ? b). In addition, Fig. 4c (top
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123panel) shows that when metformin (an activator of AMPK)
was applied to the HBE cells, NDPK phosphorylation was
almost abolished. Furthermore, a similar reduction in
NDPK phosphorylation was observed in primary nasal
brushings exposed to the cell-permeant AMP mimic,
5-aminoimidazole-4-carboxamide ribonucleoside (AICAR)
(Fig. 4c bottom panel). Finally, the two proteins were
found to colocalise at the apical membrane in primary
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123human airway biopsies (Fig. 5a), a serous airway gland cell
line (Fig. 5b) and HBE cells grown at air–liquid interface
on permeable supports (Fig. 6c). Detection of the phos-
phorylated form of AMPK at T172 is considered to be a
marker of activation. We observed that a T172 phospho-
speciﬁc antibody localised to the apical membrane of
human airway biopsies (Fig. 5c). In all instances, second-
ary antibody concentrations were such that there was no
signal when primary antibody was absent.
Having found that activation of AMPK inhibits NDPK
phosphorylation, we applied a more physiological stimulus
using hypoxia, which is recognised to activate AMPK [20].
We observe that HBE cells exposed to low oxygen (3% for
72 h) manifested a decline in NDPK activity in both
membrane and cytosol (Fig. 6a, cytosol greater than
membrane). We observed a corresponding 50% reduction
in membrane-bound total NDPK phosphorylation (1.5 min
at 4C, Fig. 6b). In addition, the co-localisation of the two
proteins in the apical membrane was no longer observed
under hypoxic conditions (Fig. 6c).
Discussion
We ﬁnd that AMPK both co-precipitates and co-localises at
the apical membrane with NDPK, and this is consistent
across several different cell types, including primary
human ciliated cells. We demonstrate that AMP differen-
tially modulates the histidine and serine phosphorylation
(pHis and pSer respectively) of NDPK that is bound to the
epithelial membrane. Surprisingly, pSer (and its augmen-
tation with [AMP]) is only apparent when GTP is the
phosphate donor. In contrast, increasing [AMP] decreases
pHis regardless of the phosphate donor (more apparent
with ATP). The mechanism by which AMPK could induce
this effect is not easy to reconcile because GTP is not
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123utilised by AMPK. Thus the simple hypothesis that AMPK
phosphorylates NDPK is not supported by our data. It
remains possible that NDPK has serine autophosphoryla-
tion activity although it seems unlikely that such a mech-
anism would discriminate between nucleoside triphosphate
donors, as we do not see this labelling with ATP, only with
GTP. The alternative explanation is that a separate kinase,
capable of utilising GTP, could be stimulated by AMP to
phosphorylate NDPK. CK2, which is known to phosphor-
ylate NDPK [3], can use GTP as well as ATP, however, the
same problem arises in that the conditions under which
CK2 might use GTP preferentially are not understood. Our
data also challenge the simple idea that NDPK merely
balances nucleotide pools indiscriminately. The combined
data suggest that complex regulation of NDPK by several
interacting kinases exists at the epithelial membrane. The
presence of phospho-serine in NDPK has been ascribed to
an artifactual transfer from high-energy phospho-histidine
to an adjacent low energy serine, which, in some instances,
is promoted by the presence of acid during the experi-
mental process. However, our data show a differential
generation of phosphoserine that cannot be attributed to
experimental artefact.
We found an unexpected potent effect of GMP relative
to AMP in its capacity to inhibit NDPK pHis content
(Fig. 1) and that the AMPK activator, AICAR stimulated
phosphorylation of a 37 kDa protein (unpublished obser-
vation). We observe (Fig. 2) that when GTP is the phos-
phate donor, a 37 kDa phosphoprotein is labelled. This is
not observed with ATP. In a previous study [6], we found
that the transfer of c-labelled phosphate from GTP (prob-
ably via membrane-bound NDPK) to annexin I occurred
differentially in the presence of two almost identical non-
hydrolysable analogues of GTP (50-guanylimidodiphos-
phate; GppNp and bc methyleneguanosine 50-triphosphate;
GppCp). The GppNp compound obliterated the transfer by
competing with GTP as expected, but the GppCp effect
was incomplete. Thus the complex of NDPK partners in
this membrane can discriminate the structure of the ter-
minal phosphate link in GTP. The effects of the equivalent
adenosine compounds on transfer from GTP were different
again, suggesting that ATP and GTP can be differentially
used as phosphate donors, at least in this particular com-
plex, and offering a much more subtle means of regulating
nucleotide and membrane metabolism. The effect of
[AMP] on NDPK is equally complex. For example, AMP is
inhibitory to NDPK phosphorylation when intact mem-
branes are studied (Fig. 1a). In contrast, when semi-puri-
ﬁed, membrane-extracted NDPK is added to a precipitate
of AMPK, AMP inhibition can be observed but AMP has
no effect on the semi-puriﬁed NDPK preparation alone
(data not shown). Thus, it is likely that the close association
of both protein kinases is required for AMP-induced NDPK
inhibition of phosphorylation. This idea is consistent with
the observed inhibitory effects of metformin and AICAR
on NDPK phosphorylation in intact cells (Fig. 4c).
Both co-immunoprecipitation and immunoﬂuorescence
techniques suggest that a complex exists between AMPK
and NDPK in airway epithelial cells. Furthermore, under
hypoxic conditions, their co-localisation in immunoﬂuo-
rescence disappears. Interestingly, several different meth-
ods of activating AMPK (AMP, AICAR, metformin and
hypoxia) all result in decreased NDPK pHis phosphoryla-
tion. We note that resting cellular pH (*6.9) lies close to
the level where pHis becomes unstable and that hypoxia
will make the cell even more acidic, creating an environ-
ment where protein modiﬁcation by phosphohistidine could
become more sensitive to regulation. We used a hypoxic
insult to mimic this effect and found that NDPK function,
measured by its ability to generate GTP, was oxygen sen-
sitive (cytosolic NDPK is more responsive to hypoxia than
the membrane-bound NDPK). AMPK would be active
under these hypoxic conditions, however, as stated above;
our data do not support the notion that AMPK phosphor-
ylates NDPK directly.
Here we present evidence for complex regulation of
NDPK activity by interacting kinases, oxygen tension and
nucleotide species. GTP has an overwhelmingly important
regulatory role at the membrane and our data suggest that
NDPK function, within this complex of proteins, is dif-
ferentially responsive to guanosine- and adenosine-con-
taining nucleotides. We speculate that it may be possible
for NDPK to switch function from phospho-transferase to
histidine kinase because our data suggest that serine
phosphorylation (from GTP) promotes kinase function
whilst inhibiting transferase function. This is mirrored
following activation of AMPK, but it remains to be seen
whether these apparently independent regulatory mecha-
nisms are interrelated.
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